Search Results

We hope you find what you’re looking for. You can email us if you need additional help.

Optimi Announces Non-Brokered Private Placement

VANCOUVER, BC – February 8, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces

Read More »

November 2023 Shareholder Update

Dear Optimi Health Shareholders, We greatly appreciate your patience and unwavering support as we navigate the intricate landscape of building and expanding our psychedelic supply enterprise. Throughout 2023, our primary focus has remained centered in Princeton, British Columbia, Canada, operating

Read More »

Products do not contain psilocybin

Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.